Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study
Saved in:
| Published in: | Infectious Diseases and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868553644566118400 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Infectious Diseases and Therapy |
| description | |
| discipline_display | Communicable Diseases, Epidemiology |
| discipline_facet | Communicable Diseases, Epidemiology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:79363 |
| institution | FRELIP |
| journal_source_facet | Infectious Diseases and Therapy |
| last_indexed | 2026-06-20T21:40:16.351Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| subject_facet | Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| title | Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study |
| title_alt | Uso previo de inhibidor de SGLT2 y metformina y riesgo de COVID prolongado en diabetes tipo 2: un estudio de cohorte poblacional a nivel nacional Utilisation antérieure d'inhibiteurs du SGLT2 et de metformine et risque de COVID long dans le diabète de type 2 : une étude de cohorte nationale basée sur la population Uso Prévio de Inibidor de SGLT2 e Metformina e Risco de COVID Longa em Diabetes Tipo 2: Um Estudo de Coorte de Base Populacional Nacional |
| title_auth | Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study |
| title_es_txt | Uso previo de inhibidor de SGLT2 y metformina y riesgo de COVID prolongado en diabetes tipo 2: un estudio de cohorte poblacional a nivel nacional |
| title_fr_txt | Utilisation antérieure d'inhibiteurs du SGLT2 et de metformine et risque de COVID long dans le diabète de type 2 : une étude de cohorte nationale basée sur la population |
| title_full | Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study |
| title_fullStr | Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study |
| title_full_unstemmed | Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study |
| title_pt_txt | Uso Prévio de Inibidor de SGLT2 e Metformina e Risco de COVID Longa em Diabetes Tipo 2: Um Estudo de Coorte de Base Populacional Nacional |
| title_short | Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study |
| title_sort | prior sglt2 inhibitor and metformin use and risk of long covid in type 2 diabetes: a nationwide population-based cohort study |
| topic | Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| url | https://link.springer.com/article/10.1007/s40121-026-01362-z |